Trimedyne, Inc. reported financial results for the first quarter ended December 31, 2013. Revenues for the quarter ended December 31, 2013, were $1,399,000, a 5.2% decrease from revenues of $1,475,000 for the prior year's quarter. The company had a net loss of $259,000 or $0.014 per share for the current quarter, compared to a loss of $144,000 or $0.008 per share for the same quarter of the prior year, based on a weighted average of 18,395,960 shares outstanding.
1st Jan change | Capi. | |
---|---|---|
+12.46% | 227B | |
+12.84% | 192B | |
+17.27% | 136B | |
+28.94% | 108B | |
+1.52% | 64.07B | |
+17.10% | 52.1B | |
+6.74% | 51.87B | |
+10.29% | 44.33B | |
+4.82% | 36.75B |